News

Piedmont Office Realty Trust Welcomes New Board Members

Piedmont Office Realty Trust Welcomes New Board Members

Piedmont Office Realty Trust Invites New Directors to Lead

Piedmont Office Realty Trust, Inc. (NYSE: PDM) is thrilled to announce the newest additions to its Board of Directors. The esteemed appointments of Deneen Donnley, Stephen Lewis, and Jeffrey Donnelly bring a wealth of knowledge and experience, strengthening the board's capacity to guide the company through its next phases of growth.

Meet the New Board Members

Deneen Donnley: Embracing Energy and Legal Expertise

Deneen Donnley has joined Piedmont's board, bringing her extensive background as the Senior Vice President and General Counsel of Consolidated Edison. This prominent energy company plays a crucial role in delivering power across the nation. Since 2020, Ms. Donnley has excelled in her role with responsibilities that include offering strategic counsel directly to the CEO and board members. Her impressive previous tenure at USAA as Executive Vice President and Chief Legal Officer showcases her strong leadership in guiding significant corporate decisions. In addition to her professional commitments, Donnley contributes to various organizations, including M1 Finance and the Leadership Council on Legal Diversity.

Stephen E. Lewis: A Legacy of Leadership

Stephen Lewis arrives at Piedmont with a formidable background that includes serving as Chair and CEO of Troutman Pepper, a significant national law firm. Over his impressive 33-year career, he occupied numerous key positions, culminating in his chairmanship in 2016. His comprehensive approach to law and deep understanding of corporate challenges helped countless clients navigate complex transactions. Lewis remains engaged with the UNC School of Law Alumni Association, further demonstrating his commitment to fostering the next generation of legal professionals.

Jeffrey J. Donnelly, CFA: Steering Hospitality and Finance

With Jeffrey Donnelly taking the stage as CEO and board member of DiamondRock Hospitality, he brings rich knowledge from the REIT sector, specifically in managing premium hotel properties. His leadership journey began in 2019 as the Executive Vice President and CFO, where he honed his skills in financial strategy prior to his elevation to CEO. Donnelly's previous experience at Wells Fargo Securities and AEW Capital Management showcases his significant expertise in asset management and capital markets. His role in the National Association of Real Estate Investment Trust's Advisory Board further evidences his commitment to industry advancements.

Welcoming New Perspectives

The addition of these accomplished professionals is met with enthusiasm by Piedmont’s Chair of the Board, Kelly H. Barrett. Barrett expressed, "This is an exciting moment in Piedmont’s lifecycle. Each of our new appointees brings a unique perspective and skill set to the boardroom, and we very much look forward to working with these outstanding individuals.” This sentiment reflects the company’s commitment to dynamic leadership and innovation.

Piedmont Office Realty Trust: A Leader in Real Estate

Piedmont Office Realty Trust, Inc. (NYSE: PDM) operates as a self-managed REIT focused on high-quality, Class A office properties primarily located in the Sunbelt region. With a robust portfolio valued at approximately $5 billion and encompassing around 16 million square feet, Piedmont prides itself on its strategic management approach. This dedication to excellence has earned the company recognition as a 2024 ENERGY STAR Partner of the Year – Sustained Excellence.

Frequently Asked Questions

What is the role of Piedmont Office Realty Trust?

Piedmont Office Realty Trust focuses on owning, managing, and developing high-quality office properties, maintaining a strategic portfolio across significant markets.

Who are the newest board members of Piedmont Office Realty Trust?

The newest board members include Deneen Donnley, Stephen Lewis, and Jeffrey Donnelly, all bringing extensive experience in their respective fields.

What qualifications does Deneen Donnley bring to the board?

Deneen Donnley has significant legal expertise and leadership experience as General Counsel for Consolidated Edison and prior roles at USAA, making her a valuable addition.

How does Stephen Lewis's experience benefit Piedmont?

Stephen Lewis’s extensive background in legal leadership and corporate strategy equips him to contribute insights pertinent to governance and business operations.

What are the areas of focus for Piedmont Office Realty Trust?

Piedmont focuses on managing high-quality Class A office properties, developing sustainable practices, and maintaining its strong financial health in the real estate market.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 308

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 9

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 26

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 321

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading

Top 5 Most Recently Viewed Articles

BioSyent Inc. to Announce Q3 Financial Results This Month

Updated Category News Views 189

BioSyent Inc. to Announce Q3 Financial Results BioSyent Inc., a prominent player in the specialty pharmaceutical industry, is preparing to release its financial results for the third quarter and year-to-date period. This important announcement is scheduled for November 20, prior to the market opening. The report will cover the company's performance for the three and nine...

Continue Reading
Dr. Ryan Egeland Joins Solventum as Chief Medical Officer

Updated Category News Views 381

Solventum Welcomes Dr. Ryan Egeland as New CMO Solventum, a pioneering healthcare company, recently announced the appointment of Dr. Ryan Egeland, MD, as their Chief Medical Officer. In this significant role, Dr. Egeland will lead the Global Medical and Clinical Affairs team, amplifying clinician and patient voices within the organization. Fostering Collaboration and...

Continue Reading
MiningToken Revolutionizes Cryptocurrency With AI Power

Updated Category News Views 186

Introducing MiningToken's Innovative AI Cloud Mining Service Bitcoin and Ethereum are experiencing remarkable market dynamics as Bitcoin persists in a bullish trend and Ethereum has gained notable ground recently. As global interest in cryptocurrencies grows, effective mining strategies are crucial for profitability. Amidst rising operational costs, many individuals seek...

Continue Reading
Saluda Medical's EVA™ Sensing Technology Approved in Europe

Updated Category News Views 111

Saluda Medical Achieves Regulatory Milestone with EVA™ Technology Saluda Medical, Inc. (ASX:SLD) has made significant strides in the medical device industry by achieving CE certification for its next-generation EVA™ Sensing Technology. This advancement not only marks a major endorsement in Europe but also is recognized in Australia. Following FDA approval in December...

Continue Reading
ReadPartner Inc. Unveils Revolutionary AI Tool to Combat Misinformation

Updated Category News Views 291

ReadPartner Inc. Launches AI Feature to Tackle Misinformation ReadPartner Inc., a leader in AI-driven media intelligence solutions, is excited to announce the upcoming launch of a groundbreaking digital security feature named ProfileScreen. This innovative tool aims to address the pressing issue of misinformation that plagues social media platforms. The ProfileScreen...

Continue Reading